| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T …
Over the last 12 months, insiders at Celularity Inc. have bought $0 and sold $0 worth of Celularity Inc. stock.
On average, over the past 5 years, insiders at Celularity Inc. have bought $4.24M and sold $23.06M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 21,410,983 shares for transaction amount of $5.33M was made by Lim Kok Thay (10 percent owner) on 2024‑01‑12.
| 2024-01-12 | Lim Kok Thay | 10 percent owner | 21.41M 11.8762% | $0.25 | $5.33M | +38.71% | ||
| 2023-10-05 | Sale | Sorrento Therapeutics, Inc. | 10 percent owner | 6.31M 21.0749% | $1.50 | $9.46M | +42.18% | |
| 2023-10-05 | Hariri Robert J | Chief Executive Officer | 9.36M 3.306% | $0.16 | $1.48M | +42.18% | ||
| 2023-09-29 | Sale | Sorrento Therapeutics, Inc. | 10 percent owner | 9.06M 30.2885% | $1.50 | $13.6M | +35.14% | |
| 2023-09-29 | Hariri Robert J | Chief Executive Officer | 9.06M 3.3418% | $0.17 | $1.5M | +35.14% | ||
| 2022-11-30 | Hariri Robert J | Chief Executive Officer | 10,000 0.0383% | $1.72 | $17,175 | -66.08% | ||
| 2022-11-29 | Hariri Robert J | Chief Executive Officer | 40,000 0.1524% | $1.71 | $68,400 | -65.27% | ||
| 2022-11-28 | Hariri Robert J | Chief Executive Officer | 40,000 0.155% | $1.74 | $69,600 | -64.36% |
| Lim Kok Thay | 10 percent owner | 51473762 158.6254% | $42.06M | 1 | 0 | +38.71% |
| Hariri Robert J | Chief Executive Officer | 28570434 88.0448% | $23.34M | 5 | 0 | <0.0001% |
$156,891,025 | 80 | -24.91% | $36.3M | |
$6,204,522 | 45 | 1.91% | $36.5M | |
$931,435 | 28 | 16.31% | $24.8M | |
$121,435,814 | 28 | 12.32% | $33.53M | |
$226,127 | 22 | -27.62% | $21.96M |
| Increased Positions | 11 | +25.58% | 172,615 | +7.51% |
| Decreased Positions | 12 | -27.91% | 258,928 | -11.26% |
| New Positions | 4 | New | 92,747 | New |
| Sold Out Positions | 6 | Sold Out | 194,266 | Sold Out |
| Total Postitions | 42 | -2.33% | 2M | -3.75% |
| C V Starr & Co Inc | $925.00 | 2.73% | 764,069 | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $819.00 | 2.42% | 676,650 | +176,518 | +35.29% | 2025-09-30 |
| Geode Capital Management, Llc | $169.00 | 0.5% | 139,314 | +4,489 | +3.33% | 2025-09-30 |
| Blackrock, Inc. | $126.00 | 0.37% | 103,833 | +768 | +0.74% | 2025-09-30 |
| Yorkville Advisors Global, Lp | $121.00 | 0.36% | 100,000 | -100,000 | -50% | 2025-09-30 |
| State Street Corp | $70.00 | 0.21% | 57,830 | -7,600 | -11.62% | 2025-09-30 |
| Valmark Advisers, Inc. | $60.00 | 0.18% | 49,983 | 0 | 0% | 2025-09-30 |
| Citadel Advisors Llc | $54.00 | 0.16% | 44,756 | -15,012 | -25.12% | 2025-09-30 |
| Renaissance Technologies Llc | $51.00 | 0.15% | 42,000 | +29,800 | +244.26% | 2025-09-30 |
| Hb Wealth Management, Llc | $49.00 | 0.14% | 40,415 | +40,415 | New | 2025-09-30 |